impact factor
logo
 

Letters to the Editor

 

Exploring the role of rheumatic and musculoskeletal disease patient organisations during the COVID-19 pandemic: results from the REUMAVID study (phase 1)


1, 2, 3, 4, 5, 6

 

  1. Health & Territory Research (HTR), Universidad de Sevilla, and Spanish Federation of Spondyloarthritis Associations (CEADE), Madrid, Spain. mcumbrera@us.es
  2. NIHR Leeds Biomedical Research Centre, Leeds Teaching Hospital Trusts, Leeds, and Leeds Institute for Rheumatic and Musculoskeletal Medicine, University of Leeds, UK.
  3. Patient Engagement, Novartis Pharma AG, Basel, Switzerland.
  4. Health & Territory Research (HTR), Universidad de Sevilla, Spain.
  5. Health & Territory Research (HTR), Universidad de Sevilla, Spain.
  6. IdiPaz, Hospital Universitario La Paz, Madrid, Spain.

on behalf of the REUMAVID Working Group.

CER15129
2022 Vol.40, N°5
PI 1062, PF 1063
Letters to the Editor

Free to view
(click on article PDF icon to read the article)

PMID: 35084328 [PubMed]

Received: 02/09/2021
Accepted : 18/11/2021
In Press: 27/01/2022
Published: 13/05/2022

Rheumatology Article